Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Investing.com - Hims & Hers Health (NYSE:HIMS) 株は木曜日の時間外取引で4.1%下落した。これはブルームバーグの報道を受けたもので、連邦取引委員会（FTC）が1年以上にわたりこの遠隔医療会社の事業慣行を調査していることが明らかになった。

The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing ...

Hims & Hers has been an incredible stock to own over the last few years, making shareholders rich. It has $2 billion in ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Investing.com - テレヘルス企業Hims & Hers ...

Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform’s third-quarter forecast ...

At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more ...

Dudum is still the largest individual holder of Hims & Hers’ stock, with the latest Form 4 showing that he owned 8 million ...